Redwood AI’s Grants, Patents, and Police Partnerships Can’t Prevent 11% OTC Rout

Redwood AI has multiplied its chemical reaction database fivefold to 21 million training examples and filed a new patent, yet the market took a sharply different view on the day its latest press campaign went live. The OTC-traded stock plunged 11.29%, underscoring the divide between operational progress and investor sentiment. At the same time, the shares showed a calmer face in Europe, rising about 1% to €2.14 on Tradegate on June 9.

The Canadian-American company filed a provisional patent with the U.S. Patent and Trademark Office on June 4. The technology, embedded in Redwood’s Reactosphere platform, is an optimization module that determines how many experimental inputs a predictive model requires to deliver reliable results. For pharmaceutical companies and defense researchers, that means shorter development cycles and lower costs — a practical edge in safety-critical fields.

Redwood’s subsidiary Redwood AI Operations Inc. landed up to 240,000 Canadian dollars under the National Research Council of Canada’s Industrial Research Assistance Program, specifically through its Defence Industry Assist branch. The funding backs the Q-SAFE project, which uses quantum-optimized methods to classify hazardous chemicals more quickly and accurately. Applications span chemical safety, defense, and public health protection.

While Redwood’s technology classifies hazardous chemicals at scale, every UK business handling dangerous substances still needs compliant on-site documentation under COSHH regulations. Many workplaces overlook substances that require formal assessment — a gap that can lead to enforcement action. The free COSHH Risk Assessment Toolkit provides 43 templates, checklists and toolbox talks to help you document your hazardous substance compliance quickly and correctly. Download the free COSHH Toolkit

Should investors sell immediately? Or is it worth buying Redwood AI?

Parallel to that, the company is participating in a British Columbia Track & Trace initiative alongside the Royal Canadian Mounted Police, the Victoria Police Department, and the Canada Border Services Agency. The platform, co-developed with Aidos Innovations since April 2026, applies generative AI and cheminformatics to detect toxic opioids. The province of British Columbia is supporting the project.

Redwood’s research partnership with the University of British Columbia has been a major driver of the data expansion. The training dataset grew from roughly 4 million to more than 21 million chemical reaction examples, a leap that directly improves the platform’s modeling accuracy.

On the quantum front, Redwood announced plans to acquire QuantumIQ, a move that would bring post-quantum cryptography capabilities — technology designed to secure communications against future quantum computer attacks. The deal has not yet closed and remains a stated intention rather than a completed transaction.

Despite the flurry of government grants, police collaborations, and a growing patent portfolio, the stock’s single-day rout highlights persistent volatility. The company’s market capitalization stood at roughly 142 million Canadian dollars in early June, and its shares have only recently begun trading on the Canadian Securities Exchange. Moreover, the press releases driving the news flow are explicitly marked as sponsored content. The lack of a finalized QuantumIQ acquisition and the absence of concrete revenue figures leave investors waiting for proof that these government-backed foundations will translate into sustainable growth.